ADCV01

· Ever Supreme Bio Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADCV01, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of ADCV01 As an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients [Phase 2]

See pricing